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tion [10]. However, vitamin C’s interaction with
ide can likely only occur at supraphysiologicales endothelial dysfunction in healthy individuals
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dothelial dysfunction, the impaired ability for
ascular dilation due to decreased production or
ioavailability of nitric oxide [1], can result from
a–reperfusion injury, a period of occlusion to a
bed followed by the rapid reintroduction of blood
this area [2,3]. Ischemia–reperfusion attenuates
tion via the production of reactive oxygen species
uring the initial minutes of reperfusion [4]. This
is mediated by the production of superoxide [5],
l sources of which include the mitochondrial elec-
sport chain [6] and NADPH oxidase [4]. Superoxide
reacts with nitric oxide to form peroxynitrite, a
eactive oxidant [5]. Hence, reducing superoxide
ion would attenuate the endothelial dysfunction
by ischemia–reperfusion injury. Noninvasive
ent of endothelial function using repeated flow-
d dilation (FMD) protocols, combined with an
ischemia–reperfusion injury has been used to
terventions to attenuate this dysfunction [7–10].
xidants’ preventive role in ischemia–reperfusion
as been suggested due to their ability to scavenge
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concentrations [12,13] and in contrast, oral supplement-
ation at reduced dosages has failed to attenuate endothelial
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340on was determined longitudinally and acute
es were not assessed. Moreover, administration
ntioxidant cocktail reduced several key indicators
mia–reperfusion injury, but not vascular constric-
5]. Critically, in these studies, the magnitude of
a (2.5 h) exceeds greatly than that during typical
easures, which may influence results [15]; further-
rotocols tested an animal model as opposed to
. Thus, the acute effect of oral antioxidant admin-
in humans has not been studied, and combining
ants could perhaps provide a higher level of pro-
from ischemia–reperfusion injury than vitamin C
ion.
ntly, studies of prolonged low flow have shown that
lial dysfunction may also manifest as enhanced
striction [16–18]. This low flow-mediated constric-
FMC) is nitric oxide independent and provides a
of resting vasomotor tone [16], which can comp-
FMD as a measure of endothelial health [19]. The
de of L-FMC is suggested to be mediated in part by
landin, endothelial hyperpolarizing factor [16], and
lin-1 (ET-1) [20] availability. During occlusion, it is
ed these pathways may be altered due to increased
de flow and subsequent production of ROS by
oxidase [18].
ed research has studied interventions to manipulate
ompared with FMD, which is surprising consider-
reported clinical importance of this measure [19,21].
tion of L-FMC was achieved via prostaglandin
e [16]; however, measurements occurred in the
ot the brachial artery, which is typically used for
ents of endothelial function using FMD [15]. Thus,
istic information regarding L-FMC in the brachial
ould allow a greater understanding of the role of
rameter in endothelial responses to ischemia–
sion injury.
difficult aspect regarding the interpretation of ische-
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teration of the diameter of the artery studied. In
ar, recent studies by van den Munckhof et al. [22]
own that upper arm occlusion for periods of 20min
n a prolonged dilation that alters baseline diameter.
cent work by Atkinson et al. [23,24] has shown the
nce of controlling for basal diameter using data
minal studies, the work in this study was assessed
oth data analysis techniques.
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k at a data analysis comparison by using baseline
r as a covariate as suggested by Atkinson et al.
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, and pressure maintained at 220mmHg. Follow-
deflation, a further three vascular function proto-
re carried out at 15, 30, and 45min of recovery.
ressure was continually monitored throughout test-
he left radial artery via arterial tonometry (model
BM-7000; Colin Medical Instruments, San Antonio,
USA) and heart rate measured via a three-lead
ardiograph. Signals were acquired via a data acqui-
ystem (PL3008 PowerLab 8/30; ADInstruments,
o Springs, Colorado, USA) and software (LabChart
struments).
ar endothelial function testing
ures
sive assessment of brachial artery vascular function
rried out using automated edge detection for
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ants
healthy participants (five women and seven
ean SD, age: 26.2 6.7 years, body mass:
6.7 kg, height: 168.2 12.7m) volunteered for the
articipants were screened prior to testing and
n criteria included smoking, pregnancy, current
ion, and presence of apparent cardiovascular or
lic disease. Women were assessed in a standardized
days 1–7) of the menstrual cycle according to
ended guidelines [25].
design and procedures
ants attended the temperature-controlled (20–228C)
ry at the same time of day on three separate
s (control, antioxidant, and ibuprofen trials), follow-
vernight fast and abstinence from caffeine. Partici-
ere also instructed to avoid strenuous exercise for
he initial test acted as a control trial. Prior to
ent visits, participants randomly ingested either
xidant cocktail [300mg a-lipoic acid, 500mg vita-
nd 200 IU vitamin E (water dispersible)] 2 h prior
rther cocktail [300mg a-lipoic acid, 500mg vita-
nd 400 IU vitamin E (water dispersible)] 1.5 h prior
1200mg of a prostaglandin inhibitor (ibuprofen)
r.
ach occasion participants arrived, were instru-
, and rested supine for 20min. Endothelial function
bsequently assessed using noninvasive vascular
protocols for the assessment of FMD and L-FMC
ight brachial artery, of which four were performed
ach trial. The first vascular function protocol (Pre)
lowed by a 10-min recovery period. After thisay arise from the inclusion of baseline diameters
riates with regard to the alterations of vascular
induced by ischemia–reperfusion and the two
tion strategies. reproduction of this article is prohibited.
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diameter analysis in real time and fast Fourier transform of
raw audio data to determine mean blood velocity (MBV).
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linear a
mode (
Japan).
to publ
M-mode
of less
(200Hz
b-stiffne
function
marked
holder
each tes
ensure t
pressure
probe w
epicond
depend
obtaine
occlusio
for a fu
was als
vascula
Data a
Basal ar
30 hear
was cal
consecu
sion dia
cycles p
L-FMC w
vascula
absolute
Basa
forearm
30 s pri
calculat
peakblo
shear ra
measure
Data a
incorp
Atkinso
approac
diamete
basal d
this met
at each
Statist
All dat
(SD). D
Kolmog
relative
time to
mean a
MBV were analyzed by two way-repeated measures
analysis of variance (ANOVA) with ‘condition’ and ‘time’
treated as within subject variables and a priori comparisons
b
ol
tr
S V
, w
ist
d
pa
oac
is,
for
ota
slo
ma
co
ma
ge
tkin
ete
a
, lo
e’ w
va
ate
ion
rs i
lat
one
ion
s w
y 1
on
ar
e d
, L-
ato
1.7
iou
s w
wi
b
ing
d
cs
ex
ine
me
it
orm
U
od
ro
t ra
ithe
Vascular injury, ibuprofen, antioxidants
Journalrray 10 Mhz Doppler ultrasound probe in triplex
Prosound Alpha 6; Hitachi Aloka Medical, Tokyo,
The FMD protocol was performed according
ished guidelines [15,25] using M-mode imaging.
imaging enables a theoretical spatial resolution
than 0.001mm and high temporal resolution
). This high spatial and time resolution also enabled
ss index to be determined prior to each vascular
measurement. The position of the probe was
using indelible ink and maintained using a probe
to ensure stable, consistent measurements and, at
ting session, previous baseline images were used to
he same portion of the vessel was assessed. A blood
cuff was placed around the forearm distal to the
ith the proximal border adjacent to the medial
yle, as recommended to assess endothelial-
ent nitric oxide dilation [15]. Arterial diameters were
d for 30 s at baseline and throughout the 5-min
n period. Postcuff deflation, the vessel was imaged
rther 3.5min. Throughout this period, blood flow
o acquired. This procedure was repeated for each
r function measure (Pre, Post15, 30, and 45).
nalysis traditional methods
terial diameter was determined as the average of
t cycles prior to cuff inflation. Peak vessel dilation
culated from the highest average diameter of three
tive heart cycles after cuff deflation, whereas occlu-
meter was determined as the average of 30 heart
rior to cuff deflation. From this data, FMD and
ere calculated as previously described [27]. Total
r reactivity (TVR) was determined as the sum of the
L-FMC and absolute FMD.
l MBV was determined for 30 s prior to the 5-min
occlusion, whereas occlusive MBV determined for
or to cuff deflation. After cuff release, MBV was
ed throughout reactive hyperemia for 60 s and the
odvelocity during this timewasdetermined. Finally,
tes were calculated (8MBV/arterial diameter at the
ment time) at these same time points.
nalysis using covariate analyses
orating basal diameters
n et al. [23] recently described an allometric-based
h to adjust relative FMD to take into account basal
r of the brachial artery. With the possibility that
iameter is altered within the current study design,
hod involves including basal diameter as a covariate
time point.
ical methods traditional approach
a are presented as mean standard deviation
ata were assessed for normal distribution using
orov–Smirnov test. Absolute and relative FMD,
L-FMC, TVR, peak blood velocity and shear rate,
peak dilation, and basal and occlusive shear rates,
rterial pressure, heart rate, b-stiffness index, and
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condition was compared to ibuprofen or antiox-
ials. Data were analyzed using statistical software
ersion 18.0; IBM Corporation, Somers, New York,
ith significance accepted as P 0.05.
ical methods analysis of covariance-
allometric approach
rate analysis was complete using an allometric
h that controls for changes in basal diameter. To
basal, maximum, and occlusion diameters were log
med and absolute dilation, absolute constriction,
l range of the log transformed data were calculated.
pe of the regression between basal diameter
ximal diameter was calculated as 0.98 and the
nfidence interval was less than 1, suggesting that
l diameter does not increase proportionally with a
in basal diameter. This agrees with previous work
son et al. [24] and suggests that controlling for basal
r is an appropriate procedure.
nalyze our FMD, L-FMC, and TVR more appropri-
g-scaled values of ‘dilation’, ‘constriction’, and ‘total
ere entered into a mixed model linear analysis
riance (ANCOVA) with ‘condition’ and ‘time’ as
d factors, ‘basal diameter’ as a covariate, and
’, ‘constriction’, and ‘total range’ as dependent
n separate analyses. Covariate-adjusted means were
ed and then back-transformed. To provide values
would typically interpret as relative dilation, con-
and total range, adjusted changes in diameter
ere calculated by subtracting 1 and then multiply-
00 according to Atkinson et al. [24]. The ‘corrected’
, constriction, and range were then interpreted and
ed to the traditional approach.
ay-to-day repeatability (coefficient of variation) for
FMC, and TVR is 15, 20, and 12%, respectively in this
ry. The absolute day-to-day difference is 1.1, 1.4,
%, respectively. Power calculation based on
s work [27] suggested a sample size of 10 partici-
ould be required to see a 1% change in FMD or L-
th a standard deviation of 2.8%, a probability of 0.05,
of 0.80. Thus, adequate statistical power was aided
a sample of 12 in repeated methods within subject
esign.
statement
perimental procedures and potential risks were
d to participants prior to testing and written
d consent obtained. The University of Essex ethics
tee approved the experimental protocol, which
ed to the Declaration of Helsinki.
LTS
ynamic responses to antioxidant,
fen, and ischemia
te and mean arterial pressures were not affected
r the administration of the antioxidant cocktail or
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ibuprofen (P> 0.05, Table 1). In addition, the ischemia–
reperfusion procedure did not alter mean arterial press-
ures (P> 0.05, Table 1). There was a reduction in heart
rate that was similar under all conditions of approximately
3–4 bpm over the course of the 2.5-h protocol (P¼ 0.04,
Table 1). Indirect measures of vascular tone derived from
brachial b-stiffness index (ultrasound imaging and pulse
pressure measures) showed no effect of time (P> 0.05,
Table 1) or condition (P> 0.05, Table 1), suggesting that
the protocol and manipulations did not alter vascular
tone.
Flow-mediated dilation and oral antioxidant or
ibuprofen administration
Reduced FMD was evident in all three conditions following
20min of forearm occlusion using the traditional statistical
approach. At 15-min after ischemia–reperfusion injury,
absolute FMD (Fig. 1a) and relative FMD (Fig. 1b) were
reduced compared with baseline values with similar
reductions under all conditions (P> 0.05). Antioxidant
administration did not preserve FMD compared with con-
trol (P> 0.05). Moreover, the pattern of recovery was not
affected by either intervention (P> 0.05), with the magni-
tude of the attenuation of FMD reducing at 30 and 45min.
Basal diameters were larger at 15min after ischemia–reper-
fusion compared with the before ischemia–reperfusion,
but returned to similar values at the 30 and 45min time
points (Fig. 2a, b, P> 0.05). However, no differences were
evident between conditions at any time point of assessment
(Fig. 2 a, b, P> 0.05). Occlusive arterial diameters during
each vascular function test replicated this response
(Fig. 2c). Finally, the time to peak vessel dilation was not
TABLE 1. Hemodynamic parameters under each condition and at each vascular function assessment
Control Ibuprofen Antioxidant
Pre Post15 Post30 Post45 Pre Post15 Post30 Post45 Pre Post15 Post30 Post45
HR (bpm) 5913a 5611 5610 559 5713a 538 559 539 5912a 5511 5410 5612
MAP (mmHg) 7910 8512 8310 8311 799 8510 808 808 8210 8110 8011 8310
b-Stiffness index 112 102 102 103 112 122 113 112 113 104 114 124
HR, heart rate; MAP, mean arterial pressure.
aDenotes a significant main effect for time (P<0.05) with Pre values significantly different from other time points within each condition.
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Reviewers’ Summary Evaluations
Reviewer 1
Strength of the study: This study addresses an interesting
subject as to the potential mechanisms involved in posti-
schemic reperfusion, as reflected by a reduced flow-medi-
ated brachial artery vasodilatation which was accentuated
in the presence of prostaglandin inhibition. The interesting
part is that supraphysiological doses of an antioxidant
cocktail did not have an effect on ischemia-induced
reduction in forearm blood flow. Although the antioxidant
cocktail was given at supraphysiological doses, it is not
known whether their concentrations were sufficient at the
site of their target. Nonetheless, these results may lead to
further exploration of the vascular effects of antioxidants.
Weakness of the study: One of the difficulties is to
understand and follow the way the study was performed
whichmakes it difficult to assess the results. One question is
whether the number of study participants was large enough
in particular for the antioxidant part of the study, since the
standard deviations for this part of the results are relatively
large and larger than for the other parts of the study.
Reviewer 2
This study investigates the effect of exogenous antioxidants
and prostaglandin inhibitors on vascular reactivity using
measurement of forearm diameter changes following
ischemic reperfusion. Findings suggest a lack of effect of
oral antioxidant ingestion on flow mediated dilation and
an amplification of the low-flow mediated constriction
due to prostaglandin suppression. Although the multiple
diameter measurements at different times present a signifi-
cant experimental limitation, functional stiffness measure-
ments provide robust support for experimental findings.
The low flow constrictor effects following ischemic reper-
fusion injury present enhanced methods of quantification
of endothelial dysfunction.
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